Mahkam Zanganeh, Co-CEO: Summit Therapeutics SMMT Buy · Filed 25/09/11

Trade details

Type: Insider buy
Amount: $5,894,405.92
Shares · price: 333,394 sh · $17.68 a share
Held after: 556,088,090 sh
Stock: Summit Therapeutics SMMT
Person: Mahkam ZanganehCo-CEO
Trade date: 25/09/10
Filed: 25/09/11
Days to filing: 1 days

First buy in 1 years

Since the last buy: 1.5 years
Last buy: 24/03/27
Insiders buying this week: 2 insiders
Holding change: +0.1%

Summit Therapeutics trades, last 26 weeks

What else happened in Summit Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/11~25/10/10

Mahkam Zanganeh's recent trades

Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$50M
3,810,000 sh
$50M
Filed 06/12
Traded 06/12
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$1.5M
100,000 sh
$1.5M
Filed 06/04
Traded 06/04
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$500K
26,680 sh
$500K
Filed 25/10/23
Traded 25/10/21
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$90.4K
5,000 sh
$90.4K
Filed 25/09/11
Traded 25/09/11
Mahkam ZanganehCEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$127.7K
34,321 sh
$127.7K
Filed 24/03/27
Traded 24/03/27